Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Canada
0
South Africa
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Beloc Duriles
2. Beloc-duriles
3. Betaloc
4. Betaloc Astra
5. Betaloc-astra
6. Betalok
7. Cgp 2175
8. Cgp-2175
9. Cgp2175
10. H 93 26
11. H 93-26
12. H 9326
13. Lopressor
14. Metoprolol
15. Metoprolol Cr Xl
16. Metoprolol Cr-xl
17. Metoprolol Tartrate
18. Seloken
19. Spesicor
20. Spesikor
21. Toprol
22. Toprol Xl
23. Toprol-xl
1. 98418-47-4
2. Metroprolol Succinate
3. Selozok
4. Toprol Xl
5. Metoprolol (succinate)
6. Seloken-zok
7. H 93/26 Succinate
8. Toprol-xl
9. Metoprolol Hemisuccinate
10. Butanedioic Acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
11. Th25pd4ccb
12. Spesicor Dos
13. Seloken Zoc
14. Beloc- Zok
15. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, Butanedioate (2:1) (salt)
16. Metoprolol Succinate [usan]
17. Unii-th25pd4ccb
18. Metoprololsuccinate
19. Metoprolol Succinate [usan:usp]
20. Toprol Xl (tn)
21. Metoprolol Succinate Extended-release Tablets
22. Metoprolol Succinate (usp)
23. (+-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol Succinate (2:1) (salt)
24. Dsstox_cid_28652
25. Dsstox_rid_82922
26. Dsstox_gsid_48726
27. Schembl40916
28. Chebi:6905
29. Chembl2356097
30. Dtxsid9048726
31. Metoprolol Succinate [mi]
32. Hms3886g21
33. Bcp02473
34. Metoprolol Succinate [vandf]
35. Tox21_113155
36. Hy-17503a
37. Metoprolol Succinate [mart.]
38. Mfcd23115896
39. S5341
40. Metoprolol Succinate [usp-rs]
41. Metoprolol Succinate [who-dd]
42. 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; Succinic Acid
43. Akos015856332
44. Bcp9000922
45. Ccg-270331
46. Cs-3158
47. Ks-1241
48. Ac-26570
49. Metoprolol Succinate [ep Impurity]
50. Metoprolol Succinate [orange Book]
51. Metoprolol Succinate [ep Monograph]
52. Cas-98418-47-4
53. Metoprolol Succinate [usp Monograph]
54. Ft-0628933
55. Dutoprol Component Metoprolol Succinate
56. D00635
57. Metoprolol Succinate Component Of Dutoprol
58. 418m474
59. A845856
60. Q-201401
61. Q27289962
62. Metoprolol Succinate, United States Pharmacopeia (usp) Reference Standard
63. Bis(1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol); Butanedioic Acid
64. Butanedioic Acid,1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
65. (+/-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol Succinate (2:1) (salt)
66. 123245-49-8
67. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+/-)-, Butanedioate (2:1) (salt)
Molecular Weight | 652.8 g/mol |
---|---|
Molecular Formula | C34H56N2O10 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 21 |
Exact Mass | 652.39349599 g/mol |
Monoisotopic Mass | 652.39349599 g/mol |
Topological Polar Surface Area | 176 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 308 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 4 | |
---|---|
Drug Name | Metoprolol succinate |
Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
Active Ingredient | Metoprolol succinate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
Market Status | Prescription |
Company | Mylan Pharms; Wockhardt; Actavis Labs Fl; Reddys; Dr Reddys Labs |
2 of 4 | |
---|---|
Drug Name | Toprol-xl |
Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
Active Ingredient | Metoprolol succinate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
Market Status | Prescription |
Company | Astrazeneca |
3 of 4 | |
---|---|
Drug Name | Metoprolol succinate |
Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
Active Ingredient | Metoprolol succinate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
Market Status | Prescription |
Company | Mylan Pharms; Wockhardt; Actavis Labs Fl; Reddys; Dr Reddys Labs |
4 of 4 | |
---|---|
Drug Name | Toprol-xl |
Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
Active Ingredient | Metoprolol succinate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
Market Status | Prescription |
Company | Astrazeneca |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Adrenergic beta-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-05-27
Pay. Date : 2021-04-19
DMF Number : 33544
Submission : 2019-03-27
Status : Active
Type : II
Date of Issue : 2022-05-02
Valid Till : 2025-05-01
Written Confirmation Number : WC-0526
Address of the Firm :
NDC Package Code : 62207-970
Start Marketing Date : 2021-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-03-19
Pay. Date : 2024-02-28
DMF Number : 18348
Submission : 2005-05-13
Status : Active
Type : II
Date of Issue : 2022-07-28
Valid Till : 2025-12-30
Written Confirmation Number : WC-0390
Address of the Firm :
NDC Package Code : 55111-851
Start Marketing Date : 2005-05-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-12
Pay. Date : 2013-09-23
DMF Number : 16621
Submission : 2003-06-19
Status : Active
Type : II
Certificate Number : CEP 2004-202 - Rev 07
Issue Date : 2024-02-27
Type : Chemical
Substance Number : 1448
Status : Valid
NDC Package Code : 53335-0005
Start Marketing Date : 2017-03-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-04
Pay. Date : 2013-06-19
DMF Number : 14612
Submission : 1999-12-09
Status : Active
Type : II
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35959
Submission : 2021-06-13
Status : Active
Type : II
Available Reg Filing : ASMF |
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-07-28
Valid Till : 2025-12-30
Written Confirmation Number : WC-0390
Address of the Firm :
NDC Package Code : 52932-0713
Start Marketing Date : 2009-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
75
PharmaCompass offers a list of Metoprolol Succinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metoprolol Succinate manufacturer or Metoprolol Succinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metoprolol Succinate manufacturer or Metoprolol Succinate supplier.
PharmaCompass also assists you with knowing the Metoprolol Succinate API Price utilized in the formulation of products. Metoprolol Succinate API Price is not always fixed or binding as the Metoprolol Succinate Price is obtained through a variety of data sources. The Metoprolol Succinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Toprol XL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Toprol XL, including repackagers and relabelers. The FDA regulates Toprol XL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Toprol XL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Toprol XL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Toprol XL supplier is an individual or a company that provides Toprol XL active pharmaceutical ingredient (API) or Toprol XL finished formulations upon request. The Toprol XL suppliers may include Toprol XL API manufacturers, exporters, distributors and traders.
click here to find a list of Toprol XL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Toprol XL DMF (Drug Master File) is a document detailing the whole manufacturing process of Toprol XL active pharmaceutical ingredient (API) in detail. Different forms of Toprol XL DMFs exist exist since differing nations have different regulations, such as Toprol XL USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Toprol XL DMF submitted to regulatory agencies in the US is known as a USDMF. Toprol XL USDMF includes data on Toprol XL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Toprol XL USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Toprol XL suppliers with USDMF on PharmaCompass.
A Toprol XL CEP of the European Pharmacopoeia monograph is often referred to as a Toprol XL Certificate of Suitability (COS). The purpose of a Toprol XL CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Toprol XL EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Toprol XL to their clients by showing that a Toprol XL CEP has been issued for it. The manufacturer submits a Toprol XL CEP (COS) as part of the market authorization procedure, and it takes on the role of a Toprol XL CEP holder for the record. Additionally, the data presented in the Toprol XL CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Toprol XL DMF.
A Toprol XL CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Toprol XL CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Toprol XL suppliers with CEP (COS) on PharmaCompass.
A Toprol XL written confirmation (Toprol XL WC) is an official document issued by a regulatory agency to a Toprol XL manufacturer, verifying that the manufacturing facility of a Toprol XL active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Toprol XL APIs or Toprol XL finished pharmaceutical products to another nation, regulatory agencies frequently require a Toprol XL WC (written confirmation) as part of the regulatory process.
click here to find a list of Toprol XL suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Toprol XL as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Toprol XL API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Toprol XL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Toprol XL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Toprol XL NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Toprol XL suppliers with NDC on PharmaCompass.
Toprol XL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Toprol XL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Toprol XL GMP manufacturer or Toprol XL GMP API supplier for your needs.
A Toprol XL CoA (Certificate of Analysis) is a formal document that attests to Toprol XL's compliance with Toprol XL specifications and serves as a tool for batch-level quality control.
Toprol XL CoA mostly includes findings from lab analyses of a specific batch. For each Toprol XL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Toprol XL may be tested according to a variety of international standards, such as European Pharmacopoeia (Toprol XL EP), Toprol XL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Toprol XL USP).